-
Over the past two decades, enterococci have emerged as important multidrug-resistant (MDR) pathogens, responsible for an increasing number of nosocomial and community-acquired invasive infections worldwide (1). The injudicious use of antibiotics in food animal production and human disease treatment has contributed to the spread of MDR enterococci in food chains (2). Enterococcus faecalis (E. faecalis) and Enterococcus faecium (E. faecium) are the two most prevalent enterococcal species identified in human infections (3). Other species, such as Enterococcus casseliflavus (E. casseliflavus), Enterococcus durans, Enterococcus gallinarum (E.gallinarum), and Enterococcus hirae (E. hirae), can also infect humans with concurrent hematological malignancies, neutropenia, and prior corticosteroid treatment (4). Identifying enterococci at the species and molecular levels is clinically relevant due to the antibacterial resistance (ABR) profiles of different isolates. E. faecium exhibits higher rates of ampicillin and vancomycin resistance than E. faecalis (5). E. gallinarum and E. casseliflavus intrinsically exhibit low-level vancomycin resistance (6). E. faecalis and E. faecium hospital-adapted sequence type (ST) and clonal complex (CC) strains (e.g., E. faecalis ST6 and CC2, and E. faecium CC17), and community-adapted lineages (e.g., E. faecium CC94 and E. faecalis ST16) have been identified (7).
The One Health approach requires integrated analysis of important bacteria from animal, food, environmental, and human sources to characterize their populations and resistance phenotypes. Given the complexity of enterococcal ABR, highlighting the One Health approach’s role in addressing this challenge is particularly important (8). Therefore, this study aimed to understand the population structure of MDR enterococcal isolates and their potential transmission risks along the food chain in China.
HTML
Citation: |